Relationship Between Pan-immune- Inflammation Value and in Major Cardiovascular and Cerebrovascular Events in Stable Coronary Artery Disease Patients Undergoing On-pump Coronary Artery Bypass Graft Surgery

Overview

Journal J Cardiothorac Surg

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
General Surgery
Pulmonary Medicine

Date 2024 Apr 17

PMID 38632613

Authors

Ahmet Dolapoglu

Eyup Avci

Affiliations

Soon will be listed here.

Abstract

Background: In this study, we aimed to evaluate the association of pan-immune-inflammation value (PIV) with major cardiovascular and cerebrovascular events (MACCE) in stable coronary artery disease patients undergoing on-pump coronary artery bypass graft (CABG) surgery.

Methods: We retrospectively analyzed data from 527 patients who underwent on-pump CABG surgery for stable coronary artery disease between June 2015 and December 2020. Patients were categorized into two groups based on MACCE development. PIV levels were calculated from blood samples taken on admission. PIV was calculated as [neutrophil count (×10/µL)×platelet count (×10/µL))×monocyte count (×10/µL)]/lymphocyte count (×10/µL). The primary endpoint was long-term major cardiovascular and cerebrovascular events (MACCE) at a median follow-up of 4.6 years.

Results: Of the included patients, 103 (19.5%) developed MACCE. PIV was higher in patients with MACCE compared to those without (470.8 [295.3-606.8] vs. 269.8 [184.3-386.4], p < 0.001). Multivariate analysis showed a significant positive association between PIV and MACCE (HR: 1.326, 95%CI:1.212-1452, p < 0.001). The cut-off value for the PIV in the estimation of MACCE was 368.28 ( AUC: 0.726 with 69% sensitivity, 71% specificity, p < 0.001).

Conclusion: This study shows a significant link between high PIV levels and MACCE in stable coronary artery disease patients undergoing on-pump CABG surgery. Our findings suggest that PIV may be a valuable, routinely available, and inexpensive marker for identifying patients at increased risk of MACCE.

Citing Articles

Association of RDW-Albumin Ratio, TG-Glucose Index, and PIV with Coronary Artery Disease.

Akkaya E J Clin Med. 2024; 13(23).

PMID: 39685462 PMC: 11642023. DOI: 10.3390/jcm13237003.

The Crucial Triad: Endothelial Glycocalyx, Oxidative Stress, and Inflammation in Cardiac Surgery-Exploring the Molecular Connections.

Curko-Cofek B, Jenko M, Taleska Stupica G, Baticic L, Krsek A, Batinac T Int J Mol Sci. 2024; 25(20).

PMID: 39456673 PMC: 11508174. DOI: 10.3390/ijms252010891.

Inflammatory and Metabolic Predictors of Mortality in Pulmonary Thromboembolism: A Focus on the Triglyceride-Glucose Index and Pan-Immune Inflammation Value.

Bilgin M, Akkaya E, Dokuyucu R J Clin Med. 2024; 13(19).

PMID: 39408068 PMC: 11477710. DOI: 10.3390/jcm13196008.

The Role of Triglyceride/HDL Ratio, Triglyceride-Glucose Index, and Pan-Immune-Inflammation Value in the Differential Diagnosis of Acute Coronary Syndrome and Predicting Mortality.

Bilgin M, Akkaya E, Dokuyucu R J Clin Med. 2024; 13(16).

PMID: 39200973 PMC: 11355828. DOI: 10.3390/jcm13164832.

References

Giakoumidakis K, Fotos N, Patelarou A, Theologou S, Argiriou M, Chatziefstratiou A . Perioperative neutrophil to lymphocyte ratio as a predictor of poor cardiac surgery patient outcomes. Pragmat Obs Res. 2017; 8:9-14. PMC: 5317302. DOI: 10.2147/POR.S130560. View

Fuca G, Beninato T, Bini M, Mazzeo L, Di Guardo L, Cimminiello C . The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy. Target Oncol. 2021; 16(4):529-536. DOI: 10.1007/s11523-021-00819-0. View

Liu Y, Ye T, Chen L, Jin T, Sheng Y, Wu G . Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coron Artery Dis. 2021; 32(8):715-720. DOI: 10.1097/MCA.0000000000001037. View

Doring Y, Soehnlein O, Weber C . Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis. Circ Res. 2017; 120(4):736-743. DOI: 10.1161/CIRCRESAHA.116.309692. View

Lievens D, von Hundelshausen P . Platelets in atherosclerosis. Thromb Haemost. 2011; 106(5):827-38. DOI: 10.1160/TH11-08-0592. View

Urbanowicz T, Michalak M, Gasecka A, Olasinska-Wisniewska A, Perek B, Rodzki M . A Risk Score for Predicting Long-Term Mortality Following Off-Pump Coronary Artery Bypass Grafting. J Clin Med. 2021; 10(14). PMC: 8305554. DOI: 10.3390/jcm10143032. View

Mohr F, Morice M, Kappetein A, Feldman T, Stahle E, Colombo A . Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013; 381(9867):629-38. DOI: 10.1016/S0140-6736(13)60141-5. View

Heeneman S, Donners M, Bai L, Daemen M . Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?. Expert Rev Cardiovasc Ther. 2007; 5(2):345-64. DOI: 10.1586/14779072.5.2.345. View

Fuca G, Guarini V, Antoniotti C, Morano F, Moretto R, Corallo S . The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials. Br J Cancer. 2020; 123(3):403-409. PMC: 7403416. DOI: 10.1038/s41416-020-0894-7. View

10.

Kocyigit D, Gurses K, Tokgozoglu L . Anti-inflammatory therapy in atherosclerosis. Front Biosci (Landmark Ed). 2019; 25(2):242-269. DOI: 10.2741/4805. View

11.

Gonzalez-Martinez S, Olona Tabuena N, Martin Baranera M, Marti-Sauri I, Moll J, Morales Garcia M . Inflammatory markers as predictors of postoperative adverse outcome in octogenarian surgical patients: an observational prospective study. Cir Esp. 2014; 93(3):166-73. DOI: 10.1016/j.ciresp.2014.08.006. View

12.

Gomez-Moreno D, Adrover J, Hidalgo A . Neutrophils as effectors of vascular inflammation. Eur J Clin Invest. 2018; 48 Suppl 2:e12940. DOI: 10.1111/eci.12940. View

13.

Mozaffarian D, Benjamin E, Go A, Arnett D, Blaha M, Cushman M . Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016; 133(4):447-54. DOI: 10.1161/CIR.0000000000000366. View

14.

Wigren M, Nilsson J, Kolbus D . Lymphocytes in atherosclerosis. Clin Chim Acta. 2012; 413(19-20):1562-8. DOI: 10.1016/j.cca.2012.04.031. View

15.

Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G . Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2012; 11(1):55-9. DOI: 10.1586/erc.12.159. View

16.

De Giorgi U, Procopio G, Giannarelli D, Sabbatini R, Bearz A, Buti S . Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab. Clin Cancer Res. 2019; 25(13):3839-3846. DOI: 10.1158/1078-0432.CCR-18-3661. View

17.

Kurtul A, Murat S, Yarlioglues M, Duran M, Ergun G, Acikgoz S . Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes. Am J Cardiol. 2014; 114(7):972-8. DOI: 10.1016/j.amjcard.2014.07.005. View

18.

Pamukcu B, Lip G, Devitt A, Griffiths H, Shantsila E . The role of monocytes in atherosclerotic coronary artery disease. Ann Med. 2010; 42(6):394-403. DOI: 10.3109/07853890.2010.497767. View

19.

Sapienza P, Mingoli A, Borrelli V, Grande R, Sterpetti A, Biacchi D . Different inflammatory cytokines release after open and endovascular reconstructions influences wound healing. Int Wound J. 2019; 16(4):1034-1044. PMC: 7949274. DOI: 10.1111/iwj.13154. View

20.

Silberman S, Abu-Yunis U, Tauber R, Shavit L, Grenader T, Fink D . Neutrophil-Lymphocyte Ratio: Prognostic Impact in Heart Surgery. Early Outcomes and Late Survival. Ann Thorac Surg. 2017; 105(2):581-586. DOI: 10.1016/j.athoracsur.2017.07.033. View